MARGINAL ZONE LYMPHOMA

Clinical trials for MARGINAL ZONE LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new MARGINAL ZONE LYMPHOMA trials appear

Sign up with your email to follow new studies for MARGINAL ZONE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 28 Not yet recruiting 1 Not yet finished but already full! 10 Completed 7 Terminated 4

New immune cell attack tested for tough blood cancers

Disease control Not yet recruiting

This early-stage study is testing the safety of a new combination treatment for people with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior therapies. The treatment adds an experimental therapy—'natural killer' (NK) immune cells from a donor—…

Matched conditions: MARGINAL ZONE LYMPHOMA

Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

MARGINAL ZONE LYMPHOMA

Get alerted when new MARGINAL ZONE LYMPHOMA trials appear

New immune cell attack tested for tough blood cancers